Vanguard Global Advisers’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
34,265
-22,844
-40% -$252K ﹤0.01% 2307
2026
Q1
$655K Buy
+57,109
New +$754K ﹤0.01% 1906

Other funds holding OFIX

Vanguard Global Advisers's OFIX Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Orthofix Medical (OFIX) stake by 40% in Q2 2026, selling an estimated $252K and leaving 34,265 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Vanguard Global Advisers first reported a position in OFIX in Q1 2026 and has held it in 2 quarters since. The position peaked at $655K in Q1 2026. 142 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Vanguard Global Advisers held 34,265 shares of Orthofix Medical worth $313K as of Q2 2026.
  • Vanguard Global Advisers sold 22,844 Orthofix Medical shares in Q2 2026, an estimated $252K.
  • Orthofix Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2307 holding.
  • Vanguard Global Advisers first reported a position in Orthofix Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Orthofix Medical position peaked at $655K in Q1 2026.
  • 142 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.